Clinical trials: FeNO
Severe Asthma, Asthma Control Level
Remission in Adults With Severe Asthma in Thailand
The goal of this observational study is to determine the prevalence of remission among adults with severe asthma, as well as the factors associated with remission in Thailand.
- Trial name
- NCT07328035
- Testing
- Global Initiative for Asthma (GINA) and Asthma Control Test (ACT) questionnaires, Spirometry, Fractional exhaled nitric oxide (FeNO) test
- Where
- Thailand
- Volunteers
- 230 people
- Sponsor
- Thammasat University
Asthma Control
OptimAIR: Towards Right Care in Asthma Through Point-of-care Phenotyping, Guideline-based Assessment and Management Optimalisation Using the AsthmaOptimiser in Primary Care
Asthma is mainly managed in primary care, yet disease control remains suboptimal. Many patients experience ongoing symptoms, exacerbations, and frequent short-acting β₂-agonist use, while underestimating the severity of their…
- Trial name
- OptimAIR (NCT07390669)
- Testing
- AsthmaOptimiser-supported structured asthma review
- Where
- 3 sites in Argentina, Chile and 1 more
- Volunteers
- 746 people
- Sponsor
- General Practitioners Research Institute
Asthma
Management of Asthma Patients Guided by Exhaled Nitric Oxide (eNO)
This study is designed to show that pharmacotherapy guided by eNO and clinical standard of care produces a superior outcome to trial-based therapy guided by clinical standard of care alone.
- Trial name
- Outcomes (NCT00739219)
- Testing
- Apieron Insight eNO monitor
- Where
- 12 sites in United States
- Volunteers
- 260 people
- Sponsor
- Apieron
Asthma
Fluctuation Analyses of Asthma Patients With Biologics Use
The goal of this observational study is to compare the fluctuation patterns of biomarkers (Spirometry, FeNO, IOS) of responders and non-responders in asthma patients who will start treatment with a biologic.
- Trial name
- FABLE (NCT06024707)
- Testing
- Biological Drug
- Volunteers
- 48 people
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Cough Variant Asthma
Validity of Fractional Exhaled Nitric Oxide and Impulse Oscillometry in Patients With Cough Variant Asthma
The aim of the research is to evaluate the clinical value of fractional exhaled nitric oxide(FeNO) ,impulse oscillometry(IOS) and mid-expiratory flow (MEF) in patients with cough variant asthma.
- Trial name
- NCT03573284
- Testing
- fractional exhaled nitric oxide(FeNO), impulse oscillometry(IOS)
- Where
- China
- Volunteers
- 146 people
- Sponsor
- Zhujiang Hospital
Radiotherapy
FENO, Extended NO Analysis and NO/CO Diffusing Capacity in Thoracic Radiation Therapy
The investigators aim to investigate the impact of thoracic radiation therapy on diffusion capacity of the lung (primary endpoint: diffusion capacity for nitric oxide, DLNO) and on exhaled nitric oxide.
- Trial name
- NCT03431740
- Where
- Switzerland
- Volunteers
- 3 people
- Sponsor
- University of Zurich
Asthma, Cystic Fibrosis
FLAME: Airway Inflammation Monitoring in Asthma and Cystic Fibrosis
Background By means of measurements of series of non-invasive inflammatory markers in exhaled breath (condensate), a reflection of inflammatory processes and oxidative stress, can be obtained.
- Trial name
- NCT00404859
- Where
- 4 sites in Netherlands
- Volunteers
- 70 people
- Sponsor
- Maastricht University Medical Center
Cough
Biomarkers for Predicting the Response to Inhaled Corticosteroid in Patients With Chronic Cough.
To investigate the value of blood eosinophils, FeNO and total IgE in predicting the response to inhaled corticosteroid in patients with chronic cough.
- Trial name
- CC-ICS (NCT05888350)
- Testing
- Beclometasone Dipropionate and Formoterol Inhalation Aerosol
- Where
- China
- Volunteers
- 502 people
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University